The Trond Mohn Foundation has newly awarded 18 millions NOK to three cancer research projects, one of which is HUVAMER-project “HUVAMER – Home Treatment for Blood Cancer” led by Professor Dr. med. Bjørn Tore Gjertsen. The HUVAMER-project is aimed to test two repurposed drug combinations (hydroxyurea + valproate, and 6-mercaptopurine + valproate) in treatment of READ MORE
The Nordic AML Group Meeting 2025 in Bergen
On September 10-12th 2025, the Nordic AML Group Meeting took its place in Bergen – Norway. The meeting was organised by the Nordic AML Group (https://www.namlg.org/) chaired by Professor Dr. med. Bjørn Tore Gjertsen. The K.G. Jebsen-Centre for Myeloid Blood Cancer (CMYC) contributed as the local organising committee, the technical organizer for the meeting, and READ MORE
Master´s degree examination
Stine Haugstvedt will present and defend her Master’s thesis: “Optimizing single-cell and immune profiling of asciminib-treated chronic myeloid leukemia patients using mass cytometry” Supervisors: Internal Examiner: Prof. Berit Johansen (NTNU)External Examiner: Dr. David Micklem (BerGenBio)
c-myc Seminar
Welcome to the upcoming double c-myc seminar Date: Thursday, August 21 Time: 13:00 – 14:00 Location: Birkhaugsalen, D305, 3rd floor, Central Block, Haukeland University Hospital with the following two presenters: 13:00 –Assoc. Prof. Morten Rye, Dept. of Clinical and Molecular Medicine, NTNU Spatial Transcriptomics Analysis of Prostate Cancer 13:20 –Prof. Berit Johansen, Dept. of Biology, NTNU Treating READ MORE
NB